
RealMoney Radio: Food and Beverage
Don't sell
Apple Computer
(AAPL) - Get Apple Inc. Report
, Jim Cramer told a caller to his
"RealMoney" radio show Thursday.
Apple's stock has no debt, and the company has a plethora of new products coming out before Christmas, he said.
Because
Advanced Micro Devices
(AMD) - Get Advanced Micro Devices Inc. Report
is locked in a price war with
Intel
(INTC) - Get Intel Corporation Report
, Cramer believes that Apple is the better buy, especially for the next three months.
When a caller asked Cramer's opinion on
Southern Copper
(PCU)
TheStreet Recommends
, the largest copper mine in Peru, he said he never recommends a stock that has been up four points in one day.
Cramer advised the caller to allow the stock to go down a couple of points before buying.
Although Cramer likes Southern Copper, he likes
Freeport-McMoRan Copper & Gold
(FCX) - Get Freeport-McMoRan Inc. Report
even more, he said, calling Freeport his play in the copper world.
The stock for
Hansen Natural
(HANS)
is up 300% from last year and 100% this year alone.
"This is a company that makes iced tea and energy drinks," Cramer said. "It will go down after it splits. I think people will sell."
Cramer told the caller wait until three days after the split to buy any of Hansen's stock.
In addition, Cramer said he'd rather see the caller in a safer beverage stock, such as
Pepsico
(PEP) - Get PepsiCo Inc. Report
, in this type of market environment.
For those who need to be in the food business, Cramer said he likes
Whole Foods
(WFMI)
and
Panera Bread
(PNRA)
.
"I like Panera better than
Starbucks
(SBUX) - Get Starbucks Corporation Report
right now," he said.
Merck
(MRK) - Get Merck & Company Inc. Report
recently received a Food and Drug Administration approval for its new drug to fight the human papillomavirus.
Although Cramer said he is thrilled that the pharmaceutical company has found a cervical cancer vaccine, he believes that medical discoveries don't necessarily translate into definite positive point for that company's stocks.
Currently Merck is in the midst of litigation over one of its drugs that is allegedly causing heart attacks.
"Merck is in the hands of the lawyers, not its scientists," Cramer said. It is not a buy, he said.
Schering-Plough
(SGP)
, which Cramer owns for his charitable trust,
Action Alerts PLUS, is a better play with no litigation risk, he said.
Cramer gave one caller the thumbs up to buy
Lowe's
(LOW) - Get Lowe's Companies Inc. Report
and told a separate caller to unload on
Wells Fargo
(WFC) - Get Wells Fargo & Company Report
, saying he likes many other stocks better than bank stocks.
To see the most recent edition of The RealMoney Radio Recap in its entirety, please click here. This recap is published every day around 3 p.m. ET.
At the time of publication, Cramer was long Schering-Plough.
Jim Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for
Action Alerts PLUS. Listen to Cramer's RealMoney Radio show on your computer; just click
here. Watch Cramer on "Mad Money" at 6 p.m. ET weeknights on CNBC. Click
here to order Cramer's latest book, "Real Money: Sane Investing in an Insane World," click
here to get his second book, "You Got Screwed!" and click
here to order Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by
clicking here.
TheStreet.com has a revenue-sharing relationship with Traders' Library under which it receives a portion of the revenue from Traders' Library purchases by customers directed there from TheStreet.com.